Publications by authors named "Peg Esper"

Claim this Profile
B
Brachytherapy: Increased Use in Patients With Intermediate- and High-Risk Prostate Cancers.
Sanna Ali, Peg Esper

Clin J Oncol Nurs· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extension of overall survival beyond objective responses in patients with metastatic renal cell carcinoma treated with high-dose interleukin-2.
David D Stenehjem, Michael Toole, Joseph Merriman, Kinjal Parikh, Stephanie Daignault, Peg Esper

Cancer Immunol Immunother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Recognition and Management of Posterior Reversible Encephalopathy Syndrome: A Newly Recognized Complication in Patients Receiving Tyrosine Kinase Inhibitors.
Ashley Przybylyski, Peg Esper

Clin J Oncol Nurs· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving documentation of quality measures in the electronic health record.
Peg Esper, Suzette Walker

J Am Assoc Nurse Pract· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying strategies to optimize care with oral cancer therapy.
Peg Esper

Clin J Oncol Nurs· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.
Michael N Neuss, Martha Polovich, Kristen McNiff, Peg Esper, Terry R Gilmore

Oncol Nurs Forum· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy.
Michael N Neuss, Martha Polovich, Kristen McNiff, Peg Esper, Terry R Gilmore

J Oncol Pract· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concepts in advanced renal carcinoma.
Peg Esper

Semin Oncol Nurs· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can you identify this lesion seen in a patient with melanoma?
Peg Esper

J Adv Pract Oncol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisions to the 2009 American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards: expanding the scope to include inpatient settings.
Joseph O Jacobson, Martha Polovich, Terry R Gilmore, Lisa Schulmeister, Peg Esper

Oncol Nurs Forum· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revisions to the 2009 american society of clinical oncology/oncology nursing society chemotherapy administration safety standards: expanding the scope to include inpatient settings.
Joseph O Jacobson, Martha Polovich, Terry R Gilmore, Lisa Schulmeister, Peg Esper

J Oncol Pract· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NCCN Task Force report: optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy.
Gary R Hudes, Michael A Carducci, Toni K Choueiri, Peg Esper, Eric Jonasch

J Natl Compr Canc Netw· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom clusters in individuals living with advanced cancer.
Peg Esper

Semin Oncol Nurs· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune modulation in melanoma and advanced cancer therapy: anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibodies.
Peg Esper

Clin J Oncol Nurs· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Melanoma: an under-recognized cancer threat.
Peg Esper

Oncology (Williston Park)· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase Ib trial assessing autologous, tumor-pulsed dendritic cells as a vaccine administered with or without IL-2 in patients with metastatic melanoma.
Bruce G Redman, Alfred E Chang, Joel Whitfield, Peg Esper, Guihua Jiang

J Immunother· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What kind of rash is it?: deciphering the dermatologic toxicities of biologic and targeted therapies.
Peg Esper, Danielle Gale, Paula Muehlbauer

Clin J Oncol Nurs· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the FACT-BRM with interferon-alpha treated melanoma patients.
Amber G Paterson, Peter C Trask, Lynne I Wagner, Peg Esper, Bruce Redman

Qual Life Res· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptom clusters in advanced illness.
Peg Esper, Debra Heidrich

Semin Oncol Nurs· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon.
Peter C Trask, Amber G Paterson, Peg Esper, Jason Pau, Bruce Redman

Psychooncology· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined-modality therapy with gemcitabine and radiotherapy as a bladder preservation strategy: results of a phase I trial.
Elizabeth Kent, Howard Sandler, James Montie, Cheryl Lee, Joseph Herman, Peg Esper

J Clin Oncol· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placental metastasis of maternal melanoma.
Jamie F Altman, Lori Lowe, Bruce Redman, Peg Esper, Jennifer L Schwartz

J Am Acad Dermatol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of oral cyclophosphamide, prednisone, and diethylstilbestrol for androgen-independent prostate carcinoma.
Beth Hellerstedt, Kenneth J Pienta, Bruce G Redman, Peg Esper, Rodney Dunn

Cancer· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of paclitaxel, estramustine, etoposide, and carboplatin in the treatment of patients with hormone-refractory prostate carcinoma.
David C Smith, Christopher H Chay, Rodney L Dunn, Jude Fardig, Peg Esper

Cancer· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of tetrathiomolybdate in patients with advanced kidney cancer.
Bruce G Redman, Peg Esper, Quintin Pan, Rodney L Dunn, Hero K Hussain

Clin Cancer Res· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis